mogroside-v and Ovarian-Neoplasms

mogroside-v has been researched along with Ovarian-Neoplasms* in 1 studies

Other Studies

1 other study(ies) available for mogroside-v and Ovarian-Neoplasms

Article	Year
Preclinical Frontiers in endocrinology, 2022, Volume: 13 The borderless transmission of coronavirus remains uncontrolled globally. The uncharted severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) variant reduces the therapeutic efficacy of vaccines against coronavirus disease 2019 (COVID-19). Clinical observations suggest that tumour cases are highly infected with coronavirus, possibly due to immunologic injury, causing a higher COVID-19-related death toll. Presently, screening of candidate medication against coronavirus is in progress. Mogroside V, a bioactive ingredient of Topics: COVID-19 Drug Treatment; Female; Humans; Molecular Docking Simulation; Ovarian Neoplasms; SARS-CoV-2; Triterpenes; Vascular Endothelial Growth Factor A	2022

Article

Year

Frontiers in endocrinology, 2022, Volume: 13

The borderless transmission of coronavirus remains uncontrolled globally. The uncharted severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) variant reduces the therapeutic efficacy of vaccines against coronavirus disease 2019 (COVID-19). Clinical observations suggest that tumour cases are highly infected with coronavirus, possibly due to immunologic injury, causing a higher COVID-19-related death toll. Presently, screening of candidate medication against coronavirus is in progress. Mogroside V, a bioactive ingredient of

Topics: COVID-19 Drug Treatment; Female; Humans; Molecular Docking Simulation; Ovarian Neoplasms; SARS-CoV-2; Triterpenes; Vascular Endothelial Growth Factor A

2022